At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,015 enrolled
Drug / intervention
Medtronic CoreValve Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CoreValve Advance International Post Market Study: Evaluation of the Medtronic CoreValve System in a "Real-World" Patient Population.
In Brief
An observational study evaluating Medtronic CoreValve System for Severe Aortic Stenosis. Completed, enrolled 1,015 participants across 44 sites in 12 countries.
Detailed Summary
The CoreValve Advance study is intended to evaluate the clinical utility of the Medtronic CoreValve System in a "Real-World" patient population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Aortic Stenosis
CountriesBelgium, Colombia, Denmark, France, Germany, Greece, Israel, Italy, Netherlands, Portugal, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 2010
Enrollment StartMar 2010
Primary CompletionNov 2011
Study CompletionMay 2017
TodayJul 2026
First PostedFeb 24, 2010
Enrollment StartMar 1, 2010
Primary CompletionNov 1, 2011
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 16.4 years ago
Interventions
Medtronic CoreValve Systemdevice
Transcatheter Aortic Valve Implantation of the Medtronic CoreValve System